https://www.doccheck.com/de/detail/articles/30242-rote-hand-brief-zu-ondexxya-andexanet-alfa-november-2020
Rote-Hand-Brief zu Ondexxya (Andexanet alfa) - November 2020 - DocCheck
Mit diesem Rote-Hand-Brief informiert der Hersteller, dass die Anwendung von Andexanet alfa vor einer Heparinisierung vermieden werden soll. Mehr...
rote handandexanet alfanovember 2020briefzu
https://www.medicines.org.uk/emc/ingredient/3195
Medicines containing the active ingredient andexanet alfa - (emc)
Medicines containing the active ingredient andexanet alfa
the activeandexanet alfamedicinescontainingingredient
https://www.acc.org/Membership/Sections-and-Councils/Cardiovascular-Team-Section/Section-Updates/2021/03/26/00/47/Key-Points-Andexanet-Alfa
Key Points | Andexanet Alfa for Anticoagulant Reversal - American College of Cardiology
key pointsandexanet alfaamerican college